Diamyd Logo
This website is only intended for investors

Fighting diabetes

Diamyd Medical is a diabetes company active in the field of pharmaceutical development. The Company is headquartered in Stockholm, Sweden and shares are listed on Nasdaq Stockholm First North (ticker: DMYD B).
Diamyd Medical tackles autoimmune type 1 diabetes on three fronts: drug development, stem cell technology and medical devices.
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, causing substantial suffering and extensive costs for society.
Diamyd Medical tackles autoimmune type 1 diabetes on three fronts: drug development, stem cell technology and medical devices. During the last quarter, the Company has advanced its positions in all of...
Diamyd® is a GAD-based therapy under development for the treatment and prevention of autoimmune diabetes such as type 1 diabetes and LADA. Treatment with Diamyd® aims to intervene in the...
rss icon
    
Senaste Årsredovisningen
pdf icon
06 november 2014, 14:30
Årsredovisning 13/14